Author: Scott Smith

2024 Year in Review​:
Therapeutics, Diagnostics, and Deep Learning Models​
​ Endometrial Cancer Endometrial Cancer New FDA Approval Dostarlimab-gxly (Jemperli) On August 1, 2024, the FDA approved dostarlimab-gxly (Jemperli, GSK)...